Published in Lab Business Week, November 5th, 2006
This trend article about Mie University, Japan is an immediate alert from IncRx to identify developing directions of research.
Study 1: Cilnidipine plus valsartan showed additive effects and caused a reduction in albuminuria in type 2 diabetics.
According to recent research published in the journal Kidney International, "Cilnidipine, an L-/N-type calcium channel blocker, dilates the efferent glomerular arterioles in an experimental model and shows a renoprotective effect, but its clinical benefits and safety have not yet been assessed in type 2 diabetics with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.